OCC 2.63% 39.0¢ orthocell limited

Ann: Quarterly Activity Report & Appendix 4C, page-17

  1. 552 Posts.
    lightbulb Created with Sketch. 35
    Forgive me for being an idiot but ... but would someone please explain to me the significant difference between the cash receipts and reported revenue?

    4C reported cash receipts for Q3 FY24 is $645k.  
    Management commentary "revenue for Q3FY24 $1.61million"

    I have a basic understanding of cash versus accrual accounting, so I get that there may be a lag between booking a sale and actually receiving the payment. But I still can't get my head around this:


    FY23 Q1-Q4 cash receipts from customers:  $1.873m
    FY23 Q1-Q4 revenue (see Figure page 2): $5.512m


    FY24 YTD Q3 cash receipts from customers:  $2.438m
    FY24 YTD Q3 revenue (see Figure 1 page 2): $4.908m



    So, for 7 quarters, FY23 + FY 24 YTD Q3

    "Cash Receipts" (4C) :  $1.873m + 2.438m = $4.311 million
    "Revenue" (Figure 2) : $5.512m + 4.908m = $10.060 million.

    Where's the missing $5.7m difference? That's a big chunk of accounts payable.....





 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
0.010(2.63%)
Mkt cap ! $81.73M
Open High Low Value Volume
38.0¢ 39.0¢ 38.0¢ $27.44K 71.05K

Buyers (Bids)

No. Vol. Price($)
3 61071 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 187536 4
View Market Depth
Last trade - 13.45pm 05/09/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.